Strengths

● Over the past year, analysts have regularly revised upwards their sales forecast for the company.

● Sales forecast by analysts have been recently revised upwards.

● For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.

● The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.


Weaknesses

● The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 39.61 times its estimated earnings per share for the ongoing year.

● The company appears highly valued given the size of its balance sheet.

● The valuation of the company is particularly high given the cash flows generated by its activity.

● The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.

● The average consensus view of analysts covering the stock has deteriorated over the past four months.

● Over the past twelve months, analysts' opinions have been revised negatively.

● The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.

● The company's earnings releases usually do not meet expectations.